Aldafermin
奥达夫明
Report date: 2025/05/15 20:00:08
Base Information
Drug NameAldafermin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[11]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNGM Biopharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesNGM Biopharmaceuticals Inc
Inactive CompaniesN/A
Active Indications +[7]
Inactive Indications +[5]
Other Information
ATC CodeN/A
Related LinksN/A